Bringing personalized medicine to reproductive health
Offer the test at your clinic

The world’s first multigene panel test for

a woman's reproductive health and fertility

The Fertilome test reveals genetic factors that are associated with some of the most common reproductive conditions in women.

Defining a new category of genetic tests

Unlike carrier screening tests, which look at the health risks for a baby, the Fertilome test reveals genetic risk factors related to reproductive conditions that may affect a woman's ability to conceive.

How the Fertilome test can work for you

By revealing genetic risk factors, the Fertilome test enables more refined diagnoses and treatment decisions than physical examinations or existing diagnostic tests alone. Using the genetic test can help you frame conversations around reproductive health and family building as a proactive journey.

Identify subclinical factors

Refine treatment plans

Counsel women with family history

Counsel egg freezing candidates

Guide targeted lifestyle counseling

Best-in-class science and standards

Our CAP-accredited, CLIA-certified labs in both NY and NJ use Next Generation Sequencing technology to deliver every patient result with the highest of quality. In a blinded reproducibility validation study, the Fertilome test achieved a 99.6% accuracy in detecting genetic variants on the panel associated with some of the most common women's reproductive conditions

Take the next step

The Fertilome genetic test requires a blood or saliva sample, and sample collection kits can be ordered by a physician. The test is available in all U.S. states. and billed directly to the patient. The Fertilome genetic test is a laboratory developed test run by Celmatix Clinical Laboratories,¹ which uses the latest in technologies and new clinical evidence for the panel.²

For physicians

Interested in offering the Fertilome test at your practice? Contact our team today.

For patients

Interested in asking your provider about the Fertilome test?

Visit MyFertilome.com

1. The Fertilome® test was developed and its performance characteristics determined by Celmatix Clinical Laboratories, a laboratory regulated under the Clinical Laboratory Improvement Amendments (CLIA) as qualified to perform high-complexity clinical testing and the test has been analytically validated in accordance with CLIA standards and is permitted by the New York State Department of Health in Molecular Genetics. The Fertilome test has not been cleared or approved by the U.S. Food and Drug Administration (FDA). The FDA does not require this test to go through premarket FDA review. The Fertilome test is not a diagnostic test. The test is available in all 50 states.

2.Fertilome test release note

Interested in taking a Fertilome test?